Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL
ClinicalTrials.gov study NCT03045328. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplant for CLL
ClinicalTrials.gov study NCT01629511. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01199575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V)
ClinicalTrials.gov study NCT03801525. IPD Sharing: NO. Countries: 1. Publications: 0.
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01510756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax
ClinicalTrials.gov study NCT04419519. IPD Sharing: YES. Countries: 1. Publications: 0.
Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01082939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
ClinicalTrials.gov study NCT01030536. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
ClinicalTrials.gov study NCT00452374. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
ClinicalTrials.gov study NCT00632359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
ClinicalTrials.gov study NCT03572634. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
ClinicalTrials.gov study NCT04722172. IPD Sharing: YES. Countries: 1. Publications: 0.
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
ClinicalTrials.gov study NCT01296932. IPD Sharing: Not stated. Countries: 3. Publications: 0.
An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01532700. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01096992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
ClinicalTrials.gov study NCT03771157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
ClinicalTrials.gov study NCT02158091. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT00290407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00860457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06644183. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.